These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2998777)

  • 1. EBV-inducing factor from platelets exhibits growth-promoting activity for NIH 3T3 cells.
    Bauer G; Birnbaum U; Höfler P; Heldin CH
    EMBO J; 1985 Aug; 4(8):1957-61. PubMed ID: 2998777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological properties of a hepatocyte growth factor from rat platelets.
    Russell WE; McGowan JA; Bucher NL
    J Cell Physiol; 1984 May; 119(2):193-7. PubMed ID: 6715417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction by growth factors from platelets of the focus-forming transformed phenotype in carcinogen-treated C3H/10T1/2 fibroblasts.
    Mordan LJ
    Carcinogenesis; 1988 Jul; 9(7):1129-34. PubMed ID: 3383332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human platelet lysate contains growth factor activities for established cell lines derived from various tissues of several species.
    Eastment CT; Sirbasku DA
    In Vitro; 1980 Aug; 16(8):694-705. PubMed ID: 7419237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor promotes proliferation of erythropoietic progenitor cells in vitro.
    Dainiak N; Davies G; Kalmanti M; Lawler J; Kulkarni V
    J Clin Invest; 1983 May; 71(5):1206-14. PubMed ID: 6853708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of human platelet factors on the proliferation of rat mesangial glomerular cells.
    Tranqui I; Duperray A; Chenais F; Alix JL; Cordonnier D
    Thromb Res; 1985 Jul; 39(2):245-51. PubMed ID: 4024055
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet-derived growth-factor requirements for in vitro proliferation of normal and malignant mesenchymal cells.
    Currie GA
    Br J Cancer; 1981 Mar; 43(3):335-43. PubMed ID: 7225284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of human platelet-derived growth factor.
    Antoniades HN; Scher CD; Stiles CD
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1809-13. PubMed ID: 287022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIH 3T3 cells transfected with a yeast H(+)-ATPase have altered sensitivity to insulin, insulin growth factor-I, and platelet-derived growth factor-AA.
    Peterson EP; Martinez GM; Martinez-Zaguilan R; Perona R; Gillies RJ
    J Cell Physiol; 1994 Jun; 159(3):551-60. PubMed ID: 8188769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the Balb/c-3T3 cell cycle-effects of growth factors.
    Stiles CD; Pledger WJ; Tucker RW; Martin RG; Scher CD
    J Supramol Struct; 1980; 13(4):489-99. PubMed ID: 6453256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bovine platelet-poor plasma on the proliferation of normal and transformed BALB/c 3T3 cells.
    Wharton W; Estes JE
    In Vitro; 1980 Jul; 16(7):554-8. PubMed ID: 7409828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of platelet-derived growth factor beta-receptor expression by mitogenic growth factors and transforming oncogenes in murine 3T3 fibroblasts.
    Vaziri C; Faller DV
    Mol Cell Biol; 1995 Mar; 15(3):1244-53. PubMed ID: 7862118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of serum components in density-dependent inhibition of growth of cells in culture. Platelet-derived growth factor is the major serum determinant of saturation density.
    Vogel A; Ross R; Raines E
    J Cell Biol; 1980 May; 85(2):377-85. PubMed ID: 7372711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factor requirements of oncogene-transformed NIH 3T3 and BALB/c 3T3 cells cultured in defined media.
    Zhan X; Goldfarb M
    Mol Cell Biol; 1986 Oct; 6(10):3541-4. PubMed ID: 3796592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinate control of 3T3 cell proliferation by platelet-derived growth factor and plasma components.
    Vogel A; Raines E; Kariya B; Rivest MJ; Ross R
    Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2810-4. PubMed ID: 275851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein factor obtained from rat adipose tissue specifically permits the proliferation of the 3T3-L1 and Ob1771 cell lines.
    Aoki N; Kawada T; Umeyama T; Sugimoto E
    Biochem Biophys Res Commun; 1990 Sep; 171(2):905-12. PubMed ID: 2206133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum stimulation of phospholipase A2 and prostaglandin release in 3T3 cells is associated with platelet-derived growth-promoting activity.
    Shier WT
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):137-41. PubMed ID: 6928609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-promoting activity of Epstein-Barr-virus-inducing factor transforming growth factor type beta (EIF/TGF-beta) is due to the induction of irreversible transformation.
    Bauer G; Götschl M; Höfler P
    Int J Cancer; 1991 Apr; 47(6):881-8. PubMed ID: 1849123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemically purified serum factor can induce both Epstein-Barr virus antigen synthesis and cell differentiation.
    Anisimová E; Roubalová K; Bauer G; Roubal J
    Arch Virol; 1987; 94(3-4):309-14. PubMed ID: 3034214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual control of cell growth by somatomedins and platelet-derived growth factor.
    Stiles CD; Capone GT; Scher CD; Antoniades HN; Van Wyk JJ; Pledger WJ
    Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1279-83. PubMed ID: 312500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.